SaNOtize is increasing production in Israel and beyond as it attempts to keep up with international demand for its Enovid nasal spray.

The Nitric Oxide Nasal Spray developed by SaNOtize is designed to kill the virus in the upper airways, preventing it from reaching the lungs.

The Vancouver-based company, co-founded by an Israeli scientist, developed a patented platform for the topical delivery of nitric oxide to treat a variety of bacterial, fungal, and viral diseases.